Search

Your search keyword '"Massoud, Cathy M."' showing total 19 results
Start Over Author "Massoud, Cathy M."
19 results on '"Massoud, Cathy M."'

8. Pembrolizumab-induced toxic epidermal necrolysis in a patient with metastatic esophageal adenocarcinoma

Author

Benjamin Gallo Marin, Rocio Oliva, Benjamin Khan, Theo Borgovan, Brooks, Blake E., and Massoud, Cathy M.

Subjects
stomatognathic diseases, Stevens-Johnson Syndrome, Humans, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Article, Skin
Abstract

Adverse cutaneous reactions associated with the immune checkpoint inhibitor (ICI) pembrolizumab are well-documented, yet life-threatening reactions such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are infrequent.(1,2) We present a case of pembrolizumab-induced TEN in a patient with metastatic esophageal adenocarcinoma who was successfully treated with cyclosporine and systemic corticosteroids.

Published
2022

15. IgA Vasculitis With Concurrent ANCA-Positivity in the Setting of Bacterial Endocarditis.

Author

XIONG, MICHELLE, SINGER, HANNAH, BAE, EDWARD, MATHIEU, REGINE, SU-JEAN SEO, and MASSOUD, CATHY M.

Subjects
*INFECTIVE endocarditis, *VASCULITIS, *IMMUNOGLOBULIN A, *IMMUNE complexes, *LEUKOCYTOCLASTIC vasculitis, *SCHOENLEIN-Henoch purpura, *CLINICAL pathology
Abstract

Cutaneous small vessel vasculitis (CSVV) or leukocytoclastic vasculitis (LCV) is a group of immune complex mediated vasculitides that affect dermal capillaries or post-capillary venules and classically presents as lower extremity palpable purpura. CSVV can be subdivided by antibody type and clinical features. In patients presenting with signs of LCV and ANCA positivity, clinicopathologic correlation is important in characterizing the type of vasculitis. We report an uncommon case of IgA vasculitis with concurrent ANCA-positivity attributed to bacterial endocarditis. [ABSTRACT FROM AUTHOR]

Published
2022

16. Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.

Author

MARIN, BENJAMIN GALLO, OLIVA, ROCÍO, KAHN, BENJAMIN, BORGOVAN, THEO, BROOKS, BLAKE ELIZABETH, and MASSOUD, CATHY M.

Subjects
*STEVENS-Johnson Syndrome, *IMMUNE checkpoint inhibitors, *TOXIC epidermal necrolysis, *ADENOCARCINOMA, *METASTASIS, *CYCLOSPORINE
Abstract

Adverse cutaneous reactions associated with the immune checkpoint inhibitor (ICI) pembrolizumab are well documented, yet life-threatening reactions such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are infrequent.1,2 We present a case of pembrolizumab-induced TEN in a patient with metastatic esophageal adenocarcinoma who was successfully treated with cyclosporine and systemic corticosteroids. [ABSTRACT FROM AUTHOR]

Published
2022

18. Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.

Author

Gallo Marin B, Oliva R, Kahn B, Borgovan T, Brooks BE, and Massoud CM

Subjects
Antibodies, Monoclonal, Humanized adverse effects, Humans, Skin, Adenocarcinoma drug therapy, Stevens-Johnson Syndrome etiology, Stevens-Johnson Syndrome therapy
Abstract

Adverse cutaneous reactions associated with the immune checkpoint inhibitor (ICI) pembrolizumab are well documented, yet life-threatening reactions such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are infrequent.1,2 We present a case of pembrolizumab-induced TEN in a patient with metastatic esophageal adenocarcinoma who was successfully treated with cyclosporine and systemic corticosteroids.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results